MedPath

effectiveness of taping in knee osteoarthritis

Not Applicable
Conditions
knee osteoarthritis.
Other primary gonarthrosis
Registration Number
IRCT2015041021673N1
Lead Sponsor
Isfahan Univercity of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
44
Inclusion Criteria

knee OA with radiological grade I,III or III (based on Kellgren-Lawrence grading scale); no presence of any inflammatory arthritis; no history of any injection at knee or any surgical intervention in this part within the last 6-month; no suspicion to other pathologies in the knee; not severe obesity; no instability of the knee joint; no cardiovascular disorders (due to cardiovascular side-effect of celecoxib); no trauma to the knee during the study;
Exclusion criteria: allergic reaction to tape or any skin problem that prevents the tape; not following the treatment by patients; performing physiotherapy within treatment schedule

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: 0-3w-6w. Method of measurement: VAS Score.;Timed Up and Go. Timepoint: 0-3w-6w. Method of measurement: The patient is observed and timed while he rises from an arm chair, walks 3 meters, turns, walks back, and sits down again.;Step test. Timepoint: 0-3w-6w. Method of measurement: The Step Test involves stepping one foot on, then off, a block as quickly as possible in 15 seconds.
Secondary Outcome Measures
NameTimeMethod
Weekly mean of analgesics consumption. Timepoint: 0-3w-6w. Method of measurement: mean number of Celecoxib 100mg capsules consumpted at last week.
© Copyright 2025. All Rights Reserved by MedPath